• HOME
  • BYLINES
    • EXECUTIVES
  • DEVICES
    • FEATURED
    • BIOTECHNOLOGY
    • CLINICAL TRIALS
  • FDA
  • IMAGING
  • MERGERS / ACQUISITIONS
  • FUNDING
  • MARKET REPORTS
  • BUSINESS
    • CAREERS
    • NURSES
  • HOSPITALS
    • NON-PROFIT
  • HEALTH
    • ARTICLES
  • HOME
  • BYLINES
    • EXECUTIVES
  • DEVICES
    • FEATURED
    • BIOTECHNOLOGY
    • CLINICAL TRIALS
  • FDA
  • IMAGING
  • MERGERS / ACQUISITIONS
  • FUNDING
  • MARKET REPORTS
  • BUSINESS
    • CAREERS
    • NURSES
  • HOSPITALS
    • NON-PROFIT
  • HEALTH
    • ARTICLES

Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence Partnership for VectorMist

Under the agreement, Caresyntax will design and operate a multi-phase real-world evidence program across a network of partner surgical facilities

July 17, 2026
« Previous Page1 Page2 Page3 Page4 Page5 Next »
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY

© 2026 All rights Reserved. Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.